Tijaria Polypipes Limited has informed the Exchange about Copy of Newspaper Publication
TIJARIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tijaria Polypipes has submitted copies of newspaper advertisements to NSE and BSE confirming publication of its standalone un-audited financial results for the quarter ended December 31, 2025, as required under SEBI listing regulations. The advertisements appeared in Business Remedies (Hindi edition) and Financial Express (English edition). The financial table in the filing, though partly unclear due to document quality, shows the company reporting figures across multiple periods (quarterly, nine-month, and full-year comparisons), with continued losses and negative basic and diluted EPS visible in the data. The filing is signed by Whole Time Director Praveen Jain Tijaria. Scrip code 533629 / symbol TIJARIA on NSE and BSE.
This is a routine regulatory compliance filing — the actual quarterly results were disclosed earlier and the stock exchanges have already been informed. No new information is being shared here, so direct impact on the share price is minimal. However, the underlying results continue to show losses and negative EPS, which remains a fundamental concern for shareholders.